07.04.2014 08:52:00

Cegedim: Improved Profitability over the First Two Months of 2014

Regulatory News :

Cegedim, a global technology and services company specializing in the healthcare field, is releasing preliminary revenues and EBIT information for the two-month period ended February 28, 2014 as a one-time announcement made in the context of a refinancing transaction launched today.

Based on preliminary financial information, consolidated revenues over the two-month period were €126.2 million, a 4.5% decrease compared to the same period in 2013 (a 3.3% decrease excluding the impact of foreign currency translation and acquisitions). EBIT over the two-month period represented a €6.2 million loss. This loss decreased by €2.1 million, or 25.5%, compared to the loss over the same period last year.

The decrease in revenues was offset by an increase in sales of higher-margin products and from ongoing cost-containment, leading to the decrease in the operating loss from recurring activities during the period.

In comparison, during the first full quarter of 2013, the Group’s revenues and EBIT were €212.9 million and €1.7 million, respectively. Approximately 38% of the Group’s revenues and almost all of the Group’s EBIT for the first quarter of 2013 were recorded during the month of March: as of March 31, 2013, Cegedim had a positive EBIT of €1.7 million, compared to a loss of €8.3 million at the end of February. Similar seasonality is expected during the first quarter of 2014.

Additionally, the first quarter of 2013 represented 24% and 3% of the full year’s revenues and EBIT respectively.

For 2014, the Group expects at least stability in its revenues and operating margin.

€ millions   Jan.- Feb. 2014   Jan.- Feb. 2013   2M 2014/2013 change
      Reported   L-f-L*
Revenues   126.2   132.1   -4.5%   -3.3%
EBIT   -6.2   -8.3   +25.5%   -
EBIT margin   -4.9%   -6.3%   -   -

* at constant scope and exchange rates

The Group’s results for the two-month period ended February 28, 2014, which are being released as a one-time announcement made in the context of the Group’s refinancing transaction, should not be considered indicative of the results that will be achieved for the first quarter of 2014 or the remainder of 2014. The Group presents these preliminary results because they reflect the continuing trends management has observed in the Group’s results of operations. However, management only performs certain closing procedures at the end of each fiscal quarter. In addition, as described above, the majority of the Group’s revenue and profit for the first quarter is generated in March. Accordingly, these preliminary results could materially differ from, and should not be viewed as a substitute for, the Group’s results of operations as presented in its audited financial statements prepared in accordance with IFRS and reviewed by the Group’s statutory auditors.

Financial calendar

April 29, 2014 (after the stock market closes)

  • Q1 2014 Revenue announcement

May 27, 2014 (after the stock market closes)

  • Q1 2014 Results announcement

Additional information

Complete financial information is available on our website: www.cegedim.com/finance.

About Cegedim :

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,000 people in more than 70 countries and generated revenue of €902.3 million in 2013. Cegedim SA is listed in Paris (EURONEXT: CGM).

To learn more, please visit: www.cegedim.com

And follow Cegedim on Twitter: @CegedimGroup

Public company with share capital of 13,336,506.43 euros
Trade and Commercial Register: Nanterre B 350 422 622
www.cegedim.com

Nachrichten zu Cegedim S.A.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cegedim S.A.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cegedim S.A. 12,25 7,46% Cegedim S.A.